Research programme: allergy vaccines - Allergy Therapeutics

Drug Profile

Research programme: allergy vaccines - Allergy Therapeutics

Alternative Names: Broad-spectrum grass allergoid vaccine - Allergy Therapeutics; Lol p1 vaccine - Allergy Therapeutics

Latest Information Update: 22 Mar 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Allergy Therapeutics
  • Class Allergy immunotherapies; Virus-like particle vaccines
  • Mechanism of Action Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Food hypersensitivity
  • Research Grass pollen hypersensitivity

Most Recent Events

  • 03 Mar 2017 Early research in Grass pollen hypersensitivity in United Kingdom
  • 03 Mar 2017 Immunogenicity data from in vitro studies in Grass pollen hypersensitivity presented at the Annual Meeting of the American Academy of Allergy, Asthma and Immunology (AAAI-2017)
  • 01 Feb 2017 Preclinical pharmacodynamics and adverse events data in Food (Peanut) allergy released by Allergy Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top